AMPHASTAR PHARMACEUTICALS IN
AMPHNASDAQ🏆 #2144 by market capUS Equity
$759.31▲ $64.24 (+8.46%)
Simulated price1h—
24h▲ 8.5%
7d—
14d—
30d—
1y—
🏦Market Cap
$869M
Small Cap
📈Revenue Growth (YoY)
+1.0%
Slowing
📊Gross Margin
47.7%
Healthy
💵FCF Margin
20.9%
Strong
⚖️P/S Ratio
1.2x
Cheap
Otter Score
66
Fair
No chart data available for AMPH.
Trading Snapshot
- Day Range
- $754.32 – $773.56
- 52-Week Range
- $16.65 – $31.26
- Volume
- $2.93B
- Avg Volume
- $2.62B
- Shares Outstanding
- 44.1M
- Next Earnings
- Oct 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $717M
- Last Q Revenue
- $181M
- P/E Ratio
- 11.3
- P/S Ratio
- 1.2x
- EPS (TTM)
- $1.71
- Dividend Yield
- —
Why Investors Own AMPH
- ✓High-growth profile — revenue up +25.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 29% gross margin and 7% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$717M▲ +22.1% YoY
Gross Margin (TTM)
28.5%▲ +0.0% YoY
Operating Income (TTM)
$130M▲ +22.1% YoY
Free Cash Flow (TTM)
$49M▲ +22.1% YoY
About AMPHASTAR PHARMACEUTICALS IN
A company profile for AMPHASTAR PHARMACEUTICALS IN isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
66/100
Analyst Price Target
ⓘAverage Target
$861.43
▲ +13.4% Upside
High Target$976.41
Low Target$707.67
Based on 22 analysts
Latest News & Updates
🚀
CNBC·2h ago
AMPHASTAR PHARMACEUTICALS IN tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift AMPH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
AMPHASTAR PHARMACEUTICALS IN announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.